McGill University Health Centre/Research Institute of the McGill University Health Centre

The Research Institute of McGill University Health Centre (RI-MUHC) is a leading academic health research organization affiliated with McGill University in Montreal, operating across six disease-focused research programs; the centre served as a clinical site for the MusKiP trial—investigating music-enhanced ketamine therapy for chronic pain—and contributes hospital infrastructure and patient populations to the Montreal Model of ketamine-assisted psychotherapy for treatment-resistant depression.